131 related articles for article (PubMed ID: 22421296)
1. Low clinically significant rate of recurrence in benign nevi.
Tallon B; Snow J
Am J Dermatopathol; 2012 Oct; 34(7):706-9. PubMed ID: 22421296
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of moderately dysplastic nevi with positive histologic margins.
Hiscox B; Hardin MR; Orengo IF; Rosen T; Mir M; Diwan AH
J Am Acad Dermatol; 2017 Mar; 76(3):527-530. PubMed ID: 28027827
[TBL] [Abstract][Full Text] [Related]
3. The role of observation in the management of atypical nevi.
Kmetz EC; Sanders H; Fisher G; Lang PG; Maize JC
South Med J; 2009 Jan; 102(1):45-8. PubMed ID: 19077745
[TBL] [Abstract][Full Text] [Related]
4. Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.
Goodson AG; Florell SR; Boucher KM; Grossman D
J Am Acad Dermatol; 2010 Apr; 62(4):591-6. PubMed ID: 20018406
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic (or Atypical) Nevi Showing Moderate or Severe Atypia With Clear Margins on the Shave Removal Specimens Are Most Likely Completely Excised.
Maghari A
J Cutan Med Surg; 2017; 21(1):42-47. PubMed ID: 27436823
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy in skin cancer clinics: the Australian experience.
Moffatt CR; Green AC; Whiteman DC
Int J Dermatol; 2006 Jun; 45(6):656-60. PubMed ID: 16796621
[TBL] [Abstract][Full Text] [Related]
7. The characteristics and second intention healing after shave excision of nevi on the lid margin in East Asians.
Chang M; Park M; Baek S; Oh JH
J Craniofac Surg; 2013; 24(5):e467-70. PubMed ID: 24036816
[TBL] [Abstract][Full Text] [Related]
8. Negative predictive value of biopsy margins of dysplastic nevi: A single-institution retrospective review.
Duncan JR; Purnell JC; Stratton MS; Pavlidakey PG; Huang C; Phillips CB
J Am Acad Dermatol; 2020 Jan; 82(1):87-93. PubMed ID: 31326466
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and positive predictive values of presurgical clinical diagnosis of excised benign and malignant skin tumors: a prospective study of 835 lesions in 778 patients.
Har-Shai Y; Hai N; Taran A; Mayblum S; Barak A; Tzur E; Schafer I; David R; David E; Linn S
Plast Reconstr Surg; 2001 Dec; 108(7):1982-9. PubMed ID: 11743388
[TBL] [Abstract][Full Text] [Related]
10. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
11. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.
Strazzula L; Vedak P; Hoang MP; Sober A; Tsao H; Kroshinsky D
J Am Acad Dermatol; 2014 Dec; 71(6):1071-6. PubMed ID: 25262175
[TBL] [Abstract][Full Text] [Related]
12. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
Kim CC; Berry EG; Marchetti MA; Swetter SM; Lim G; Grossman D; Curiel-Lewandrowski C; Chu EY; Ming ME; Zhu K; Brahmbhatt M; Balakrishnan V; Davis MJ; Wolner Z; Fleming N; Ferris LK; Nguyen J; Trofymenko O; Liu Y; Chen SC;
JAMA Dermatol; 2018 Dec; 154(12):1401-1408. PubMed ID: 30304348
[TBL] [Abstract][Full Text] [Related]
13. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
14. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
Fleming NH; Egbert BM; Kim J; Swetter SM
JAMA Dermatol; 2016 Dec; 152(12):1327-1334. PubMed ID: 27542070
[TBL] [Abstract][Full Text] [Related]
15. Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.
Comfere NI; Chakraborty R; Peters MS
J Am Acad Dermatol; 2013 Nov; 69(5):687-692. PubMed ID: 23932648
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and management of eyelid margin nevi.
Custer PL; Council ML
Orbit; 2024 Feb; 43(1):8-15. PubMed ID: 36688501
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of biopsies and excisions of dysplastic acral nevi: a study of 187 lesions.
Bronsnick T; Kazi N; Kirkorian AY; Rao BK
Dermatol Surg; 2014 Apr; 40(4):455-9. PubMed ID: 24456372
[TBL] [Abstract][Full Text] [Related]
18. To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions.
Mendese G; Maloney M; Bordeaux J
Dermatol Surg; 2014 Oct; 40(10):1077-83. PubMed ID: 25229784
[TBL] [Abstract][Full Text] [Related]
19. What Is the Best Method for Removing Biopsy-Proven Atypical Nevi? A Comparison of Margin Clearance Rates Between Reshave and Full-Thickness Surgical Excisions.
Jeon H; Wang YJ; Smart C
Dermatol Surg; 2015 Sep; 41(9):1020-3. PubMed ID: 26230329
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic nevus syndrome with development of multiple melanomas. A surgical concept for prophylaxis.
Brod C; Schippert W; Breuninger H
J Dtsch Dermatol Ges; 2009 Sep; 7(9):773-5. PubMed ID: 19456853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
